<i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
Li Guan(Stanford Medicine), Quynh‐Thu Le(Stanford Medicine)
Cited by 56
Related Papers
Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
|Journal of Clinical Investigation|2019|174
Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03
|Journal of Clinical Oncology|2009|87